Alivus Life Sciences Ltd.

A decrease in the sales to Rs. 5068.79 millions was observed for the quarter ended September 2024. The sales stood at Rs. 5953.63 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 953.16  millions from Rs. 1187.37 millions ,decline by -19.73%.A decline of 1428.92 millions was observed in the OP in the quarter ended September 2024 from 1724.53 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202409	202309	% Var	202409	202309	% Var	202403	202303	% Var
Sales	5068.79	5953.63	-14.86	10954.95	11738.13	-6.67	22832.14	21612.20	5.64
Other Income	85.33	53.69	58.93	140.26	72.20	94.27	120.42	289.57	-58.41
PBIDT	1428.92	1724.53	-17.14	3078.70	3674.65	-16.22	6862.88	6712.50	2.24
Interest	3.43	3.99	-14.04	6.96	7.95	-12.45	15.46	5.47	182.63
PBDT	1425.49	1720.54	-17.15	3071.74	3666.70	-16.23	6847.42	6707.03	2.09
Depreciation	150.93	131.29	14.96	294.80	257.41	14.53	534.52	420.94	26.98
PBT	1274.56	1589.25	-19.80	2776.94	3409.29	-18.55	6312.90	6286.09	0.43
TAX	321.40	401.88	-20.03	708.95	867.42	-18.27	1604.02	1616.48	-0.77
Deferred Tax	19.00	14.88	27.69	31.38	44.43	-29.37	81.88	110.37	-25.81
PAT	953.16	1187.37	-19.73	2067.99	2541.87	-18.64	4708.88	4669.61	0.84
Equity	245.06	245.05	0.00	245.06	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	28.19	28.97	-2.68	28.10	31.31	-10.23	30.06	31.06	-3.22